Pfizer PAC Our Voices. Our Impact. Pfizer PAC and Corporate Political Contributions Report January 2015 – December 2016 Pfizer PAC – Our Voices. Our Impact. A Message from Sally Susman, Chair, Pfizer PAC I am pleased to share our 2016 election cycle political contributions report, which includes a list of candidates and political committees supported either by Pfizer or the Pfizer PAC from January 1, 2015, through December 31, 2016. The Pfizer PAC is bipartisan; we contribute to candidates of both political parties and we do not contribute to Presidential candidates. Pfizer PAC and Pfizer Inc supported 2,420 candidates and multiple political committees at all levels of the government. 56% of the funds went to Republicans and 44% went to Democrats. I hope you will take time to review the report to see which candidates the PAC supported in your state and community. Patients continue to face significant legislative and regulatory challenges, and each election cycle is a new opportunity for lawmakers to either help or hinder patient access to innovative medicines. We are focused on making sure it’s the former. Our elected representatives are making difficult choices, including focusing on cost reductions that could fundamentally alter our ability to discover and develop new cures and therapies for those who are counting on us to help make their lives better. Our priority is to help build a constructive discourse in the political and regulatory environment to support our business priorities. Those priorities include the protection of intellectual property, supporting a patient centric healthcare system that enables access and encourages innovation, protecting patients from dangerous counterfeit medicines, protecting Medicare Part D, a program with 90% satisfaction among beneficiaries, and enacting a contemporary tax code that rewards innovation. At the state level, we are working to reform insurer barriers that delay and deny care, reduce out- of-pocket costs for patients, eliminate regulatory and legislative barriers to accessing biosimilars, innovative vaccines and consumer products, and pass civil justice reform legislation. As Pfizer’s PAC Chair, and through my interactions with elected officials, I see first-hand how decisions are made that impact our ability to discover and bring to market innovative medicines and vaccines as well as off-patent medicines that patients and physicians rely on every day. Thank you for your support, Sally Susman Chair, Pfizer PAC 2 PFIZER PAC Our Voices. Our Impact. What is a PAC? Who Receives Pfizer PAC Contributions? PAC stands for Political Action Committee. A political action Pfizer PAC is nonpartisan. committee is a It supports Democrats and government-regulated Republicans alike. From January organization that anyone can 2015 through Decmeber 2016, form to raise money for Pfizer PAC supported 2,420 political campaign donations. candidates. True to its nonpartisan PACs are formed by values, Pfizer PAC is committed individuals, non-profits, and to support candidates from both even many major corporations. political parties who share Pfizer’s vision and values for healthcare. How Does Pfizer PAC Work? When choosing to make a contribution to a candidate, the The Pfizer political action Pfizer PAC considers candidates’ committee, Pfizer PAC, is a views on issues that impact Pfizer nonpartisan organization that and its employees as well as the provides opportunities for presence of Pfizer facilities or employees to participate in the employees in the candidate’s American political process. The district or state. A complete list Pfizer PAC is an employee-run of Pfizer PAC and state corporate organization with a Steering political contributions for January Committee made up of Pfizer 2015 - December 2016 is included employees from different in this report. divisions of the company. All corporate PACs are funded by voluntary employee contributions. Pfizer PAC is no different; it relies on the participation of Pfizer colleagues. 3 PFIZER PAC & POLITICAL CONTRIBUTIONS GOVERNANCE POLICY Pfizer complies fully with all federal, state, and local laws and reporting requirements governing PAC and corporate political contributions. Pfizer has a Corporate Policy Procedure (#802a) that requires all PAC and corporate political contributions to be compiled and published semiannually in a report that is made available to employees, shareholders, and the public, and posted on the Company’s website at www.pfizer.com in “Lobbying and Political Contributions” under the “About Pfizer” tab within the “Corporate Governance” section. At the end of each Federal cycle (every two years), the Pfizer PAC is audited by Bond Beebe, a certified public accounting and advisory firm. Pfizer also requests that trade associations receiving total payments of $100,000 or more from Pfizer in a given year report the portion of Pfizer dues or payments used for expenditures or contributions that, if made directly by Pfizer, would not be deductible under section 162(e)(1)(B) of the Internal Revenue Code. We are disclosing such information received from our trade associations in this report. Pfizer has a PAC Steering Committee comprised of eight colleagues who review and approve all PAC and corporate political contributions on a monthly basis. To ensure adequate representation, Steering Committee members represent different divisions within the Pfizer organization. The PAC Steering Committee evaluates candidates on a basis of their views on issues that impact Pfizer and its colleagues. It also takes note of whether Pfizer facilities or colleagues reside in a candidate’s district or state. In addition, all PAC and corporate contribution requests are shared with the Pfizer Political Contributions Policy Committee for review. The Political Contributions Policy Committee is responsible for governing the Pfizer PAC. Pfizer does not traditionally make contributions to 527 Issue Organizations. If we were asked to make such a contribution, it would have to be reviewed and approved by the Political Contributions Policy Committee and subsequently disclosed in our semi-annual report. Finally, in light of the Supreme Court decision in the Citizens United case, Pfizer will not make any direct independent expenditures, a decision which has been discussed at the executive level as well as with the Corporate Governance Committee of our Board. 4 Political Contributions Policy Committee CHAIR Ken Cole Tony Maddaluna Sally Susman Senior Vice President, Executive Vice President & Executive Vice President, US Government Relations President, Corporate Affairs Pfizer Global Supply TREASURER Robert Jones Marc Scarduffa Joseph Gruber Vice President, Vice President, Senior Vice President, National Government Relations US Government Relations & Global Tax US Public Affairs SECRETARY Jeff Keisling Andrew Schmeltz Barbara Bonfiglio Senior Vice President, Senior Vice President, Assistant General Counsel, Chief Information Officer, Patient & Health Impact, Corporate Governance Business Technology Pfizer Innovative Health Doug Lankler Julie Schiffman Executive Vice President Vice President, Chief General Counsel Portfolio & Decision Analysis Margaret Madden Susan Silbermann Senior Vice President & President & General Manager, Corporate Secretary, Global Vaccines Chief Governance Counsel Rod MacKenzie John Young Executive Vice President, Group President, Chief Development Officer, Pfizer Essential Health Global Product Development Group Pfizer PAC Steering Committee David Blackwell Richard Dudek John F. Kelly Senior Director, Vice President Vice President, Research & Development Specialty Access Solutions Strategy & Transitioning Sites Groton, CT Itasca, IL New York, NY Sheryl Colyer Michael Flesher Dennis Ryan Vice President, Director, Key Account Manager, Human Resources Pfizer Medical Pfizer Essential Health New York, NY Chicago, IL La Jolla, CA Patrick Doyle Mike Hoffman Group Lead, Vice President, Pfizer Essential Health Global Procurement New York, NY Peapack, NJ 5 Pfizer PAC Our Voices. Our Impact. Political Contributions Recipients January 2015 – December 2016 Pfizer Political Contributions RecipientsJanuary 2015 - December 2016 Debt State/Office Win Full Name Facility Future Party District Corp PAC Retirement Election ALABAMA US HOUSE W Rep. Robert Brown Aderholt R 004 $5,000.00 W Rep. Bradley Roberts Byrne R 001 $2,000.00 W Rep. Martha Roby R 002 $2,000.00 W Rep. Terri Andrea Sewell D 007 $3,500.00 STATE SENATE Sen. Del Marsh R 012 $1,000.00 STATE HOUSE Rep. Jack Williams R 047 $1,000.00 ALASKA US SENATE W Sen. Lisa Ann Murkowski R $5,000.00 ARIZONA US SENATE Sen. Jeffrey Lane Flake (Up in ‘18) R $1,000.00 US HOUSE W Rep. Andrew S. Biggs R 005 $5,000.00 W Rep. Ruben M. Gallego D 007 $2,000.00 Matthew James Salmon R $2,500.00 W Rep. Kyrsten Sinema D 009 $3,000.00 GOVERNOR Gov. Doug Ducey (Up in ‘18) R $3,000.00 STATE ATTORNEY GENERAL AG Mark Brnovich (Up in ‘18) R $1,500.00 STATE SENATE W Sen. Nancy K. Barto R 015 $1,000.00 Sen. Nancy K. Barto (Up in ‘18) R 015 $400.00 Carlyle W. Begay R 007 $300.00 Rep. Andrew S. Biggs R 012 $400.00 W Sen. Sonny Borrelli R 005 $600.00 Sen. Sean Bowie (Up in ‘18) D 018 $400.00 W NP Winner Non-Partisan Debt-Retirement Facility 7 Pfizer Political Contributions RecipientsJanuary 2015 - December 2016 Debt State/Office Win Full Name Facility Future Party District Corp PAC Retirement Election W Sen. David T. Bradley D 010 $500.00 W Sen. Kate Brophy McGee R 028 $1,250.00 Sen. Kate Brophy McGee (Up in ‘18) R 028 $400.00 W Sen. Judy M. Burges R 022 $400.00 W Sen. Lupe Chavira Contreras D 019 $400.00 Jeff Dial R 018 $800.00 Adam Driggs R 028 $400.00 W Sen. Karen Elizabeth Fann R 001 $600.00 W Sen. Steve Farley D 009 $500.00 Sen. Steve Farley (Up in ‘18) D 009 $400.00 W Sen. Gail Griffin R 014 $600.00 W Sen. Katie Hobbs D 024 $800.00 Sen. Katie Hobbs (Up in ‘18) D 024 $400.00 W Sen. John Kavanagh R 023 $300.00 W Sen. Debbie Lesko R 021 $700.00 Eric Meyer D 028 $900.00 W Sen.